San Francisco, CA

SPIE Photonics West 2016 conference

Conference / 1.2.2016

A wearable continuous-wave optical device for continuous monitoring during chemotherapy infusions.
© Fraunhofer CMI

A wearable continuous-wave optical device for continuous monitoring during chemotherapy infusions.

Fraunhofer CMI and their research collaborators present their latest work in biomedical engineering at the SPIE Photonics West 2016 conference. Around 20,000 visitors are expected at the SPIE Photonics West 2016 conference in mid-February 2016 in San Francisco, CA, to see the latest research and development in the field of laser, photonics, and biomedical optics. The work of Fraunhofer CMI's engineers and scientists will be presented at the SPIE Photonics West BiOS EXPO in the conference program tracks of Biomedical Spectroscopy, Microscopy, and Imaging and Photonic Therapeutics and Diagnostics.

Tuesday, 16 February: Biomedical Spectroscopy, Microscopy, and Imaging

Fraunhofer CMI and their research collaborators of the BU-Fraunhofer Alliance for Medical Devices, Instrumentation and Diagnostics collaborate to accelerate promising technologies from the research stage to the marketplace. At the conference they will be presenting their project of "A wearable continuous-wave optical device for continuous monitoring during neoadjuvant chemotherapy infusions" in the session for »Optical Diagnostics and Sensing XVI: Toward Point-of-Care Diagnostics« as a new method for optical blood oxygenation measurements.

Researchers: Fei Teng, Boston Univ. (USA); Timothy Cormier, Alexis Sauer-Budge, Fraunhofer CMI/Fraunhofer USA, Inc. (USA); Darren M. Roblyer, Boston Univ. (USA)

Saturday 13, February: Photonic Therapeutics and Diagnostics

Fraunhofer CMI and The Center for Future Technologies in Cancer Care (CFTCC) at Boston University collaborate based on the translational core of the BU-Fraunhofer Alliance model. Together they worked on the "Design of an everting balloon to deploy a micro endoscope to the fallopian tubes" as a contribution to new »Diagnosis and Treatment of Diseases in the Breast and Reproductive System II« in Gynecology.

Researchers: Molly Keenan, Caitlin Howard, Tyler Tate, The Univ. of Arizona (USA); John Black, Glannaventa, Inc. (USA); Urs Utzinger, Jennifer K. Barton, The Univ.of Arizona (USA)